John P. Zimmer
Massachusetts Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John P. Zimmer.
Nature Biotechnology | 2007
Hak Soo Choi; Wenhao Liu; Preeti Misra; Eiichi Tanaka; John P. Zimmer; Binil Itty Ipe; Moungi G. Bawendi; John V. Frangioni
The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by >15 nm and prevented renal excretion. A final hydrodynamic diameter <5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.
Nature Medicine | 2005
Mark Stroh; John P. Zimmer; Dan G. Duda; Tatyana Levchenko; Kenneth Cohen; Edward B. Brown; David T. Scadden; Vladimir P. Torchilin; Moungi G. Bawendi; Dai Fukumura; Rakesh K. Jain
A solid tumor is an organ composed of cancer and host cells embedded in an extracellular matrix and nourished by blood vessels. A prerequisite to understanding tumor pathophysiology is the ability to distinguish and monitor each component in dynamic studies. Standard fluorophores hamper simultaneous intravital imaging of these components. Here, we used multiphoton microscopy techniques and transgenic mice that expressed green fluorescent protein, and combined them with the use of quantum dot preparations. We show that these fluorescent semiconductor nanocrystals can be customized to concurrently image and differentiate tumor vessels from both the perivascular cells and the matrix. Moreover, we used them to measure the ability of particles of different sizes to access the tumor. Finally, we successfully monitored the recruitment of quantum dot–labeled bone marrow–derived precursor cells to the tumor vasculature. These examples show the versatility of quantum dots for studying tumor pathophysiology and creating avenues for treatment.
Cancer Research | 2006
Trevor D. McKee; Paola Grandi; Wilson Mok; George Alexandrakis; Numpon Insin; John P. Zimmer; Moungi G. Bawendi; Yves Boucher; Xandra O. Breakefield; Rakesh K. Jain
Oncolytic viral therapy provides a promising approach to treat certain human malignancies. These vectors improve on replication-deficient vectors by increasing the viral load within tumors through preferential viral replication within tumor cells. However, the inability to efficiently propagate throughout the entire tumor and infect cells distant from the injection site has limited the capacity of oncolytic viruses to achieve consistent therapeutic responses. Here we show that the spread of the oncolytic herpes simplex virus (HSV) vector MGH2 within the human melanoma Mu89 is limited by the fibrillar collagen in the extracellular matrix. This limitation seems to be size specific as nanoparticles of equivalent size to the virus distribute within tumors to the same extent whereas smaller particles distribute more widely. Due to limited viral penetration, tumor cells in inaccessible regions continue to grow, remaining out of the range of viral infection, and tumor eradication cannot be achieved. Matrix modification with bacterial collagenase coinjection results in a significant improvement in the initial range of viral distribution within the tumor. This results in an extended range of infected tumor cells and improved virus propagation, ultimately leading to enhanced therapeutic outcome. Thus, fibrillar collagen can be a formidable barrier to viral distribution and matrix-modifying treatments can significantly enhance the therapeutic response.
ACS Nano | 2008
Numpon Insin; Joseph B. Tracy; Hakho Lee; John P. Zimmer; Robert M. Westervelt; Moungi G. Bawendi
We describe the synthesis of magnetic and fluorescent silica microspheres fabricated by incorporating maghemite (gamma-Fe2O3) nanoparticles (MPs) and CdSe/CdZnS core/shell quantum dots (QDs) into a silica shell around preformed silica microspheres. The resultant approximately 500 nm microspheres have a narrow size distribution and show uniform incorporation of QDs and MPs into the shell. We have demonstrated manipulation of these microspheres using an external magnetic field with real-time fluorescence microscopy imaging.
Journal of the American Chemical Society | 2006
Preston T. Snee; Rebecca C. Somers; Gautham Nair; John P. Zimmer; Moungi G. Bawendi; Daniel G. Nocera
Journal of the American Chemical Society | 2006
John P. Zimmer; Sang-Wook Kim; Shunsuke Ohnishi; Eichii Tanaka; John V. Frangioni; Moungi G. Bawendi
Angewandte Chemie | 2004
Jonathan S. Steckel; John P. Zimmer; Seth Coe-Sullivan; Nathan E. Stott; Vladimir Bulovic; Moungi G. Bawendi
Journal of the American Chemical Society | 2007
Wenhao Liu; Hak Soo Choi; John P. Zimmer; Eiichi Tanaka; John V. Frangioni; Moungi G. Bawendi
Advanced Materials | 2004
Yinthai Chan; John P. Zimmer; Mark Stroh; Jonathan S. Steckel; Rakesh K. Jain; Moungi G. Bawendi
Angewandte Chemie | 2006
Jonathan S. Steckel; Preston T. Snee; Seth Coe-Sullivan; John P. Zimmer; Jonathan E. Halpert; Polina Anikeeva; Lee Ann Kim; Vladimir Bulovic; Moungi G. Bawendi